HK1033271A1 - Multiparticulate pharmaceutical form with programmed and timed release and preparation method - Google Patents

Multiparticulate pharmaceutical form with programmed and timed release and preparation method

Info

Publication number
HK1033271A1
HK1033271A1 HK01103971A HK01103971A HK1033271A1 HK 1033271 A1 HK1033271 A1 HK 1033271A1 HK 01103971 A HK01103971 A HK 01103971A HK 01103971 A HK01103971 A HK 01103971A HK 1033271 A1 HK1033271 A1 HK 1033271A1
Authority
HK
Hong Kong
Prior art keywords
pharmaceutical form
active principle
timed release
polymer
hours
Prior art date
Application number
HK01103971A
Inventor
Edouard Gendrot
Gerard Cousin
Francoise Ragot
Marie-Christine Clee-Bouvet
Original Assignee
Prographarm Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Prographarm Lab filed Critical Prographarm Lab
Publication of HK1033271A1 publication Critical patent/HK1033271A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Abstract

The invention concerns a mutliparticulate pharmaceutical form with delayed and timed release for starting to make the active principle available 4 to 8 hours after said pharmaceutical form has been ingested, then for gradually releasing the totality of the active principle within the following 8 to 20 hours. The invention is characterised in that it is free of organic acid and it is in the form of medicated spheroids consisting of a neutral spherical carrier comprising a first coating based on a mixture of at least a water soluble polymer and at least a water insoluble polymer wherein are uniformly distributed particles constituting an active principle, the whole comprising a second coating based on at least two independent pH polymers, having degrees of permeability with respect to different gastric and intestinal environments, optionally at least a dependent pH polymer, at least a plasticising agent and at least an inert filler distributed in said coating.
HK01103971A 1998-05-20 2001-06-11 Multiparticulate pharmaceutical form with programmed and timed release and preparation method HK1033271A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9806384A FR2778848B1 (en) 1998-05-20 1998-05-20 MULTIPARTICULATE PHARMACEUTICAL FORMULA WITH PULSED RELEASE AND ITS PREPARATION METHOD
PCT/FR1999/001201 WO1999059557A1 (en) 1998-05-20 1999-05-20 Multiparticulate pharmaceutical form with programmed and timed release and preparation method

Publications (1)

Publication Number Publication Date
HK1033271A1 true HK1033271A1 (en) 2001-08-24

Family

ID=9526556

Family Applications (1)

Application Number Title Priority Date Filing Date
HK01103971A HK1033271A1 (en) 1998-05-20 2001-06-11 Multiparticulate pharmaceutical form with programmed and timed release and preparation method

Country Status (25)

Country Link
EP (1) EP1077687B1 (en)
JP (1) JP2002515423A (en)
KR (1) KR100583065B1 (en)
CN (1) CN1186014C (en)
AT (1) ATE214598T1 (en)
AU (1) AU758299B2 (en)
BG (1) BG64764B1 (en)
BR (1) BR9910606A (en)
CA (1) CA2333188C (en)
DE (1) DE69901062T2 (en)
DK (1) DK1077687T3 (en)
ES (1) ES2173739T3 (en)
FR (1) FR2778848B1 (en)
GE (1) GEP20022750B (en)
HK (1) HK1033271A1 (en)
HU (1) HU224193B1 (en)
IL (1) IL139774A (en)
MX (1) MXPA00011364A (en)
NO (1) NO330501B1 (en)
NZ (1) NZ508392A (en)
PL (1) PL192950B1 (en)
PT (1) PT1077687E (en)
TR (1) TR200100107T2 (en)
WO (1) WO1999059557A1 (en)
ZA (1) ZA200006768B (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8071128B2 (en) 1996-06-14 2011-12-06 Kyowa Hakko Kirin Co., Ltd. Intrabuccally rapidly disintegrating tablet and a production method of the tablets
US9358214B2 (en) 2001-10-04 2016-06-07 Adare Pharmaceuticals, Inc. Timed, sustained release systems for propranolol
US8367111B2 (en) 2002-12-31 2013-02-05 Aptalis Pharmatech, Inc. Extended release dosage forms of propranolol hydrochloride
US8802139B2 (en) 2003-06-26 2014-08-12 Intellipharmaceutics Corp. Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient
US10624858B2 (en) 2004-08-23 2020-04-21 Intellipharmaceutics Corp Controlled release composition using transition coating, and method of preparing same
US8747895B2 (en) 2004-09-13 2014-06-10 Aptalis Pharmatech, Inc. Orally disintegrating tablets of atomoxetine
US9884014B2 (en) 2004-10-12 2018-02-06 Adare Pharmaceuticals, Inc. Taste-masked pharmaceutical compositions
CA2584957C (en) 2004-10-21 2015-08-25 Eurand Pharmaceuticals Limited Taste-masked pharmaceutical compositions with gastrosoluble pore-formers
AU2013273835B2 (en) * 2005-05-02 2016-07-07 Adare Pharmaceuticals, Inc. Timed, pulsatile release systems
US9161918B2 (en) 2005-05-02 2015-10-20 Adare Pharmaceuticals, Inc. Timed, pulsatile release systems
US10064828B1 (en) 2005-12-23 2018-09-04 Intellipharmaceutics Corp. Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems
US10960077B2 (en) 2006-05-12 2021-03-30 Intellipharmaceutics Corp. Abuse and alcohol resistant drug composition
WO2008136016A1 (en) * 2007-05-08 2008-11-13 Medreich Limited A stable controlled release oral solid dosage form composition and a process thereof
WO2011067667A2 (en) 2009-12-02 2011-06-09 Eurand Pharmaceuticals Limited Fexofenadine microcapsules and compositions containing them
FR2999432B1 (en) 2012-12-17 2014-12-12 Ethypharm Sa ORODISPERSIBLE COMPRESSES OBTAINED BY COMPRESSION MOLDING

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2558396B2 (en) * 1990-06-28 1996-11-27 田辺製薬株式会社 Controlled release formulation
US5567441A (en) * 1995-03-24 1996-10-22 Andrx Pharmaceuticals Inc. Diltiazem controlled release formulation
FR2754710B1 (en) * 1996-10-22 1998-12-31 Prographarm Lab PROCESS FOR THE PREPARATION OF A MULTIPARTICULAR PHARMACEUTICAL FORM WITH CONTROLLED RELEASE PLURISEQUENTIELLE

Also Published As

Publication number Publication date
WO1999059557A1 (en) 1999-11-25
NO330501B1 (en) 2011-05-02
IL139774A0 (en) 2002-02-10
EP1077687B1 (en) 2002-03-20
ES2173739T3 (en) 2002-10-16
DK1077687T3 (en) 2002-06-17
AU758299B2 (en) 2003-03-20
HUP0102027A3 (en) 2002-12-28
PT1077687E (en) 2002-09-30
KR20010052370A (en) 2001-06-25
NZ508392A (en) 2002-09-27
DE69901062D1 (en) 2002-04-25
BR9910606A (en) 2001-10-02
AU3830299A (en) 1999-12-06
JP2002515423A (en) 2002-05-28
MXPA00011364A (en) 2008-09-09
HUP0102027A2 (en) 2002-03-28
ZA200006768B (en) 2001-11-20
EP1077687A1 (en) 2001-02-28
FR2778848B1 (en) 2001-11-23
GEP20022750B (en) 2002-08-26
TR200100107T2 (en) 2001-06-21
CN1186014C (en) 2005-01-26
CA2333188C (en) 2010-07-06
BG104963A (en) 2001-07-31
PL344314A1 (en) 2001-10-22
FR2778848A1 (en) 1999-11-26
NO20005838L (en) 2001-01-10
CA2333188A1 (en) 1999-11-25
PL192950B1 (en) 2006-12-29
ATE214598T1 (en) 2002-04-15
DE69901062T2 (en) 2002-10-31
NO20005838D0 (en) 2000-11-17
HU224193B1 (en) 2005-06-28
IL139774A (en) 2005-09-25
KR100583065B1 (en) 2006-06-08
CN1305371A (en) 2001-07-25
BG64764B1 (en) 2006-03-31

Similar Documents

Publication Publication Date Title
PL344314A1 (en) Multiparticulate pharmaceutical form with programmed and timed release and preparation method
AU2001239658A1 (en) Method for producing a controlled-release preparation
NO870558D0 (en) PROCEDURE FOR THE PREPARATION OF A SLOW RELEASE PHARMACEUTICAL PREPARATION.
CA2351814A1 (en) Taste masked pharmaceutical particles
CA2141582A1 (en) Pelletised pharmaceutical composition
PT1207860E (en) Controlled release pellet formulation
ATE204747T1 (en) RETARD MATRIX PELLETS AND METHOD FOR THE PRODUCTION THEREOF
IL151150A0 (en) Multiparticulate drug form comprising at least two differently coated pellet forms
WO2001034119A3 (en) Inhibitors of crystallization in a solid dispersion
WO2004091528A3 (en) Delivery systems of homogeneous thermoreversible alginate films
NO20013336D0 (en) Pharmaceutical preparations
CY1107695T1 (en) METHOD OF PRODUCTION OF COATED TABLETS WITH COVERED TASTE AND IMMEDIATE DETERMINATION OF THE ACTIVE FACTOR
DK1663217T3 (en) Solid dispersions containing tacrolimus
CA2352211A1 (en) Sustained release matrix systems for highly soluble drugs
DK1417960T3 (en) Sustained-release micropellets and methods for making them
WO2006006691A3 (en) Solid dispersion of a p38 map kinase inhibitor
BG104757A (en) Pellets having a core coated with a lipid lowering agent and a polymer
WO2001051031A3 (en) Enteric coated pharmaceutical formulation

Legal Events

Date Code Title Description
PF Patent in force
PE Patent expired

Effective date: 20190519